0001144204-11-031290.txt : 20110520
0001144204-11-031290.hdr.sgml : 20110520
20110520105755
ACCESSION NUMBER: 0001144204-11-031290
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110512
FILED AS OF DATE: 20110520
DATE AS OF CHANGE: 20110520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VAN OORT DOUGLAS M
CENTRAL INDEX KEY: 0001518733
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54384
FILM NUMBER: 11860106
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1726 MEDICAL BOULEVARD, SUITE 201
STREET 2: SUITE 201
CITY: NAPLES
STATE: FL
ZIP: 34108
BUSINESS PHONE: 9419231949
MAIL ADDRESS:
STREET 1: 1726 MEDICAL BOULEVARD, SUITE 201
STREET 2: SUITE 201
CITY: NAPLES
STATE: FL
ZIP: 34108
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
4
1
form441638_052011105747-.xml
X0303
4
2011-05-12
0
0001077183
NEOGENOMICS INC
NGNM.OB
0001518733
VAN OORT DOUGLAS M
C/O NEOGENOMICS, INC.
12701 COMMONWEALTH DRIVE SUITE 9
FORT MYERS
FL
US 33913
1
1
0
0
Chairman and CEO
Common Stock
2011-05-12
4
P
0
1000
1.4
A
788890
I
Trust by Self
Common Stock
2011-05-17
4
P
0
1110
1.4
A
790000
I
Trust by Self
Common Stock
8600
D
Stock option (right to buy)
0.8
2009-12-31
2016-03-15
Common Stock
0
1000000
D
Warrant (right to buy)
1.05
2009-03-16
2014-03-15
Common Stock
0
625000
D
On March 15, 2009 Mr. VanOort was granted options to purchase 1,000,000 shares. The grant was comprised of 500,000 time based options and 500,000 performance based options. The first date of vesting when an option became exercisable was December 31, 2009 when 200,000 performance based options vested. Mr. VanOort will have 374,000 time based options vested and exercisable within 60 days of this filing. There are 300,000 performance based options which are not vested or exercisable.
On March 16, 2009 Mr. VanOort was granted a warrant to purchase 625,000 shares. Of this total 125,000 warrants were immediately exercisable and vested. The remaining 500,000 warrants vest based on performance of the Company stock price and are not exercisable or vested at the present time.
/s/ Douglas VanOort
2011-05-20